标题:The Hedgehog pathway: role in cell differentiation, polarity and proliferation
作者:Jia, Yanfei;Wang, Yunshan;Xie, Jingwu
作者机构:[Jia, Y] Central Laboratory, Jinan Central Hospital Affiliated to Shandong University, Jinan, China, Division of Hematology and Oncology, Department o 更多
通讯作者:Xie, JW
通讯作者地址:[Xie, JW]Indiana Univ, Simon Canc Ctr, Wells Ctr Pediat Res, Div Hematol & Oncol,Dept Pediat, Indianapolis, IN 46202 USA.
来源:Archives of Toxicology
出版年:2015
卷:89
期:2
页码:179-191
DOI:10.1007/s00204-014-1433-1
关键词:Hedgehog;Smoothened;PTCH1;Cancer;Signal transduction;Clinical trials;Animal model
摘要:Hedgehog (Hh) is first described as a genetic mutation that has \"spiked\" phenotype in the cuticles of Drosophila in later 1970s. Since then, Hh signaling has been implicated in regulation of differentiation, proliferation, tissue polarity, stem cell population and carcinogenesis. The first link of Hh signaling to cancer was established through discovery of genetic mutations of Hh receptor gene PTCH1 being responsible for Gorlin syndrome in 1996. It was later shown that Hh signaling is associated with many types of cancer, including skin, leukemia, lung, brain and gastrointestinal cancers. Another important milestone for the Hh research field is the FDA approval for the clinical use of Hh inhibitor Erivedge/Vismodegib for treatment of locally advanced and metastatic basal cell carcinomas. However, recent clinical trials of Hh signaling inhibitors in pancreatic, colon and ovarian cancer all failed, indicating a real need for further understanding of Hh signaling in cancer. In this review, we will summarize recent progress in the Hh signaling mechanism and its role in human cancer.
收录类别:SCOPUS;SCIE
WOS核心被引频次:20
Scopus被引频次:23
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922061178&doi=10.1007%2fs00204-014-1433-1&partnerID=40&md5=33560f8143a63d6b7ee1e6d64931dbd7
TOP